These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 26769045

  • 1. Induction of Angiogenesis by a Type III Phosphodiesterase Inhibitor, Cilostazol, Through Activation of Peroxisome Proliferator-Activated Receptor-γ and cAMP Pathways in Vascular Cells.
    Sanada F, Kanbara Y, Taniyama Y, Otsu R, Carracedo M, Ikeda-Iwabu Y, Muratsu J, Sugimoto K, Yamamoto K, Rakugi H, Morishita R.
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):545-52. PubMed ID: 26769045
    [Abstract] [Full Text] [Related]

  • 2. Cilostazol stimulates revascularisation in response to ischaemia via an eNOS-dependent mechanism.
    Hori A, Shibata R, Morisaki K, Murohara T, Komori K.
    Eur J Vasc Endovasc Surg; 2012 Jan; 43(1):62-5. PubMed ID: 21852163
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
    Sahara M, Sata M, Morita T, Nakajima T, Hirata Y, Nagai R.
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
    [Abstract] [Full Text] [Related]

  • 5. Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ.
    Biscetti F, Pecorini G, Arena V, Stigliano E, Angelini F, Ghirlanda G, Ferraccioli G, Flex A.
    Mol Cell Endocrinol; 2013 Dec 05; 381(1-2):80-7. PubMed ID: 23891623
    [Abstract] [Full Text] [Related]

  • 6. Cilostazol Promotes Angiogenesis and Increases Cell Proliferation After Myocardial Ischemia-Reperfusion Injury Through a cAMP-Dependent Mechanism.
    Li J, Xiang X, Xu H, Shi Y.
    Cardiovasc Eng Technol; 2019 Dec 05; 10(4):638-647. PubMed ID: 31625080
    [Abstract] [Full Text] [Related]

  • 7. Cilostazol promotes angiogenesis after peripheral ischemia through a VEGF-dependent mechanism.
    Biscetti F, Pecorini G, Straface G, Arena V, Stigliano E, Rutella S, Locatelli F, Angelini F, Ghirlanda G, Flex A.
    Int J Cardiol; 2013 Aug 10; 167(3):910-6. PubMed ID: 22473072
    [Abstract] [Full Text] [Related]

  • 8. Metformin stimulates ischemia-induced revascularization through an eNOS dependent pathway in the ischemic hindlimb mice model.
    Takahashi N, Shibata R, Ouchi N, Sugimoto M, Murohara T, Komori K.
    J Vasc Surg; 2015 Feb 10; 61(2):489-96. PubMed ID: 24993950
    [Abstract] [Full Text] [Related]

  • 9. Cilostazol promotes mitochondrial biogenesis in human umbilical vein endothelial cells through activating the expression of PGC-1α.
    Zuo L, Li Q, Sun B, Xu Z, Ge Z.
    Biochem Biophys Res Commun; 2013 Mar 29; 433(1):52-7. PubMed ID: 23485471
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A novel vasculo-angiogenic effect of cilostazol mediated by cross-talk between multiple signalling pathways including the ERK/p38 MAPK signalling transduction cascade.
    Chao TH, Tseng SY, Li YH, Liu PY, Cho CL, Shi GY, Wu HL, Chen JH.
    Clin Sci (Lond); 2012 Aug 01; 123(3):147-59. PubMed ID: 22339730
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model.
    Aoki M, Morishita R, Hayashi S, Jo N, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T.
    Diabetologia; 2001 Aug 01; 44(8):1034-42. PubMed ID: 11484082
    [Abstract] [Full Text] [Related]

  • 16. In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade.
    Hashiya N, Jo N, Aoki M, Matsumoto K, Nakamura T, Sato Y, Ogata N, Ogihara T, Kaneda Y, Morishita R.
    Circulation; 2004 Jun 22; 109(24):3035-41. PubMed ID: 15173033
    [Abstract] [Full Text] [Related]

  • 17. A novel model of chronic limb ischemia to therapeutically evaluate the angiogenic effects of drug candidates.
    Shimatani K, Sato H, Saito A, Sasai M, Watanabe K, Mizukami K, Kamohara M, Miyagawa S, Sawa Y.
    Am J Physiol Heart Circ Physiol; 2021 Mar 01; 320(3):H1124-H1135. PubMed ID: 33481698
    [Abstract] [Full Text] [Related]

  • 18. Combination of Cilostazol and L-Carnitine Improves Walking Performance in Peripheral Arterial Disease Model Rats.
    Shiga T, Sahara H, Orito K.
    Pharmacology; 2015 Mar 01; 96(5-6):210-6. PubMed ID: 26329263
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease.
    Schellinger IN, Cordasic N, Panesar J, Buchholz B, Jacobi J, Hartner A, Klanke B, Jakubiczka-Smorag J, Burzlaff N, Heinze E, Warnecke C, Raaz U, Willam C, Tsao PS, Eckardt KU, Amann K, Hilgers KF.
    Kidney Int; 2017 Mar 01; 91(3):616-627. PubMed ID: 27927598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.